Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, November 10, 2009, 8:18AM ET - U.S. Markets open in 1 hour and 12 minutes. Dow Up 2.03% Nasdaq  0.00%
Charles River Laboratories International Inc. (CRL)On Nov 9: 33.69   0.00 (0.00%)  
MORE ON CRL
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Charles River Laboratories International Inc.
251 Ballardvale Street
Wilmington, MA 01887
United States - Map
Phone: 781-222-6000
Fax: 978-988-9236
Web Site: http://www.criver.com

DETAILS 
Index Membership:S&P 400 MidCap
S&P 1500 Super Comp
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:9,000

BUSINESS SUMMARY 
Charles River Laboratories International, Inc. provides research models and laboratory animal support expertise to help its global partners advance their research and drug development efforts. The company offers a portfolio of services to support discovery and imaging, preclinical and early-phase clinical studies, and biopharmaceutical and endotoxin products and services for manufacturing and quality control. Its portfolio spans the entire research and drug development process, from IND consultation to discovery through market approval, allowing customized approaches to support both single-study or broad-based programs. Charles River Laboratories International serves pharmaceutical and biotechnology companies, as well as government agencies, hospitals, and academic institutions. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Charles River Laboratories International Inc.


    CORPORATE GOVERNANCE 
    Charles River Laboratories International Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 98% of S&P 400 companies and 100% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. James C. Foster JD, 58
    Chairman, Chief Exec. Officer, Pres and Member of Exec. Committee
    $ 1.77M $ 1.81M
    Mr. Thomas F. Ackerman , 54
    Chief Financial Officer and Corp. Exec. VP
    $ 733.00K $ 502.00K
    Mr. Real H. Renaud , 61
    Corp. Exec. VP and Pres of Global Research Model Products & Services
    $ 882.00K $ 1.17M
    Dr. Nancy A. Gillett D.V.M, Ph.D., D.A.C.V.P., 53
    Corp. Exec. VP and Pres of Global Pre-Clinical Services
    $ 551.00K $ 483.00K
    Mr. David P. Johst , 47
    Chief Admin. Officer, Corp. Exec. VP of HR, Sec. and Gen. Counsel
    $ 807.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis